Drug Type Universal CAR-T |
Synonyms CD94-UCAR-T, CT 7590, CT7590 |
Target |
Action inhibitors |
Mechanism CD94 inhibitors(killer cell lectin like receptor D1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Plasma Cell Leukemia | Clinical | China | 12 Apr 2023 | |
| Recurrent Multiple Myeloma | Clinical | China | 12 Apr 2023 | |
| Relapse multiple myeloma | Clinical | China | 12 Apr 2023 |





